Testing focused radiation with and without an extra edge for cancer that spread to the brain
Official title: Frameless Stereotactic Radiosurgery for Intact Brain Metastases
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study tests whether a tighter radiation target works as well for tumors that spread to the brain.
Read our full plain-language summary
What the trial team says
This is a randomized study to determine if not treating planning target volume (PTV) margins during radiation therapy worsens progression free survival rates in patients with brain metastases.
Key facts
- Registry number
- NCT02747303
- Stage of testing
- Phase 2
- Conditions studied
- Brain Metastases
Where it is running
This trial lists 1 site.
-
Illinois
- University of Chicago (Chicago)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.